Figure 4.

rAAV2-hPEDF inhibited growth and metastasis in CRPC model, and prolonged survival time of treated mice. A: Representative photographs and H&E staining of abdominal tumors in NS (a), rAAV2-null (b), and rAAV2-hPEDF (c) groups; B: Mean number and weight of tumor nodules in each group; C: Survival curves of mice in each group; D: Body weight of mice in each group; E: Photographs of major organs after intraperitoneal administration of rAAV2-hPEDF and NS (×400).

Wu et al. BMC Cancer 2012 12:129   doi:10.1186/1471-2407-12-129
Download authors' original image